Data / Form D filings / Hypercell Technologies Inc.
Hypercell Technologies Inc.: Form D filing
Hypercell Technologies Inc., a biotechnology company in Ithaca, NY, filed a Form D with the SEC in 2026. The latest, on October 14, 2026, reports $3 million sold of a $4.4 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 95 Brown Rd., Ithaca, NY, 14850
- Phone
- (404) 661-8856
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1882357
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14 | New notice | $4,423,378 | $2,958,378 | $1,465,000 | 14 | Sep 8 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bruno Georges Jactel | Executive Officer, Director | |
| Loic DeBlais | Executive Officer | |
| Samuel Jactel | Executive Officer, Director | |
| James Cali | Director | |
| Tony Puri | Director |
Other biotechnology companies in New York that filed recently
- CAD Therapeutics, Inc. $4 million · Oct 2
Every Form D from the week of Oct 12 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Hypercell Technologies Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.